Skip to main content
SpringerLink
Log in

Cannabis Use Disorder: A Behavioral Economic Perspective

  • Cannabis (R Tomko & B Sherman, Section Editors
  • Published:
Current Addiction Reports Aims and scope Submit manuscript

Abstract 

Purpose of Review

To explore relations between behavioral economic demand for cannabis and cannabis use disorder (CUD). Prior reviews have focused on drug demand in relation to use outcomes more generally. Complementing and enhancing prior work synthesizing research on cannabis demand, the present review endeavors to determine whether specific demand indices derived from the marijuana purchase task are most reliably related to CUD. Additionally, sociodemographic characteristics of participants in these studies were reviewed to identify whether certain populations were underrepresented in behavioral economic cannabis research.

Recent Findings

Behavioral economic demand is related to CUD; intensity and elasticity of cannabis demand were consistently associated with CUD diagnosis and severity. However, frequently, only select demand indices were assessed or reported, precluding the ability to confirm which indices are superior for denoting CUD risk. Further, most studies enrolled samples that were predominately young adults, Caucasian, and male.

Summary

As CUD becomes more prevalent in the wake of cannabis legalization, identification of robust predictors of CUD risk is paramount. Cannabis demand is consistently associated with CUD; however, individual indices of import in this relationship remain ambiguous. Subsequent research is needed to confirm index-specific markers of disordered cannabis use, and whether links between demand and CUD generalize across diverse populations.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

Notes

  1. Study corresponding authors were contacted for additional study-related information when further clarification was deemed necessary.

References

Papers of particular interest, published recently, have been highlighted as: •• Of major importance

  1. Hasin DS, Saha TD, Kerridge BT, Goldstein RB, Chou SP, Zhang H, et al. Prevalence of marijuana use disorders in the United States between 2001–2002 and 2012–2013. JAMA Psychiat. 2015;72:1235–42.

    Article  Google Scholar 

  2. Goodman S, Wadsworth E, Leos-Toro C, Hammond D. International Cannabis Policy Study team. Prevalence and forms of cannabis use in legal vs. illegal recreational cannabis markets. Int J Drug Policy. 2020;76:102658.

    Article  PubMed  Google Scholar 

  3. United Nations. World Drug Report 2020. 2020.

  4. Pew Research Center. Majority now supports legalizing marijuana. 2013.

  5. Mariani AC, Williams AR. Perceived risk of harm from monthly cannabis use among US adolescents: National Survey on Drug Use and Health, 2017. Prev Med Rep. 2021;23:101436.

    Article  PubMed  PubMed Central  Google Scholar 

  6. Roditis ML, Delucchi K, Chang A, Halpern-Felsher B. Perceptions of social norms and exposure to pro-marijuana messages are associated with adolescent marijuana use. Prev Med. 2016;93:171–6.

    Article  PubMed  PubMed Central  Google Scholar 

  7. ElSohly MA, Mehmedic Z, Foster S, Gon C, Chandra S, Church JC. Changes in cannabis potency over the last 2 decades (1995–2014): analysis of current data in the United States Biological Psychiatry. Elsevier. 2016;79:613–9.

    CAS  Google Scholar 

  8. Chandra S, Radwan MM, Majumdar CG, Church JC, Freeman TP, ElSohly MA. New trends in cannabis potency in USA and Europe during the last decade (2008–2017).European Archives of Psychiatry and Clinical Neuroscience. Springer Berlin Heidelberg; 2019;269:5–15

  9. Smart R, Caulkins JP, Kilmer B, Davenport S, Midgette G. Variation in cannabis potency and prices in a newly legal market: evidence from 30 million cannabis sales in Washington state. Addiction. 2017;112:2167–77.

    Article  PubMed  PubMed Central  Google Scholar 

  10. Meier MH. Associations between butane hash oil use and cannabis-related problems. Drug Alcohol Depend. 2017;179:25–31.

    Article  CAS  PubMed  Google Scholar 

  11. Loflin M, Earleywine M. A new method of cannabis ingestion: the dangers of dabs? Addict Behav. 2014;39:1430–3.

    Article  PubMed  Google Scholar 

  12. Cinnamon Bidwell L, YorkWilliams SL, Mueller RL, Bryan AD, Hutchison KE. Exploring cannabis concentrates on the legal market: user profiles, product strength, and health-related outcomes. Addict Behav Rep. 2018;8:102–6.

    CAS  PubMed  PubMed Central  Google Scholar 

  13. Cavazos-Rehg PA, Krauss MJ, Sowles SJ, Floyd GM, Cahn ES, Chaitan VL, et al. Leveraging user perspectives for insight into cannabis concentrates. Am J Drug Alcohol Abuse. 2018;44:628–41.

    Article  PubMed  PubMed Central  Google Scholar 

  14. Bickel WK, Crabbe JC, Sher KJ. What is addiction? How can animal and human research be used to advance research, diagnosis, and treatment of alcohol and other substance use disorders? Alcohol Clin Exp Res. 2019;43:6–21.

    Article  PubMed  Google Scholar 

  15. American Psychiatric Association. DSM-5, 5th edition. 5th ed. Washington, D.C: American Psychiatric Publishing; 2013.

    Google Scholar 

  16. Hasin DS, Shmulewitz D, Sarvet AL. Time trends in US cannabis use and cannabis use disorders overall and by sociodemographic subgroups: a narrative review and new findings. American Journal of Drug and Alcohol Abuse. Taylor & Francis; 2019;45:623–43.

  17. Substance Abuse and Mental Health Services Administration. Key substance use and mental health indicators in the United States: results from the 2018 National Survey on Drug Use and Health (HHS Publication No. PEP19–5068, NSDUH Series H-54). Rockville, MD; 2019.

  18. GBD 2016 Alcohol and Drug Use Collaborators. The global burden of disease attributable to alcohol and drug use in 195 countries and territories, 1990–2016: a systematic analysis for the Global Burden of Disease Study 2016. Lancet Psychiatry. 2018;5:987–1012.

    Article  Google Scholar 

  19. Hall W, Renström M, Poznyak V. The health and social effects of nonmedical cannabis use. World Health Organization; 2016.

  20. Blanco C, Hasin DS, Wall MM, Flórez-Salamanca L, Hoertel N, Wang S, et al. Cannabis use and risk of psychiatric disorders: prospective evidence from a US national longitudinal study. JAMA Psychiat. 2016;73:388–95.

    Article  Google Scholar 

  21. Buckner JD, Schmidt NB, Bobadilla L, Taylor J. Social anxiety and problematic cannabis use: evaluating the moderating role of stress reactivity and perceived coping. Behav Res Ther. 2006;44:1007–15.

    Article  PubMed  Google Scholar 

  22. Kroon E, Kuhns L, Hoch E, Cousijn J. Heavy cannabis use, dependence and the brain: a clinical perspective. Addiction. 2020;115:559–72.

    Article  PubMed  Google Scholar 

  23. Looby A, Earleywine M. Negative consequences associated with dependence in daily cannabis users. Subst Abuse Treat Prev Policy. 2007;2:3.

    Article  PubMed  PubMed Central  Google Scholar 

  24. Callaghan RC, Allebeck P, Sidorchuk A. Marijuana use and risk of lung cancer: a 40-year cohort study. Cancer Causes Control. 2013;24:1811–20.

    Article  PubMed  Google Scholar 

  25. Fergusson DM, Horwood LJ, Beautrais AL. Cannabis and educational achievement. Addiction. 2003;98:1681–92.

    Article  PubMed  Google Scholar 

  26. Fergusson DM, Boden JM. Cannabis use and later life outcomes. Addiction. 2008;103:969–76 (discussion 977-978).

    Article  PubMed  Google Scholar 

  27. Rup J, Freeman TP, Perlman C, Hammond D. Cannabis and mental health: prevalence of use and modes of cannabis administration by mental health status. Addict Behav. Oxford: Pergamon-Elsevier Science Ltd; 2021;121:106991.

  28. Arterberry BJ, Treloar Padovano H, Foster KT, Zucker RA, Hicks BM. Higher average potency across the United States is associated with progression to first cannabis use disorder symptom. Drug Alcohol Depend. 2019;195:186–92.

    Article  PubMed  Google Scholar 

  29. Bidwell LC, Martin-Willett R, Karoly HC. Advancing the science on cannabis concentrates and behavioural health. Drug Alcohol Rev. 2021;40:900–13.

    Article  PubMed  Google Scholar 

  30. Loflin MJE, Kiluk BD, Huestis MA, Aklin WM, Budney AJ, Carroll KM, et al. The state of clinical outcome assessments for cannabis use disorder clinical trials: a review and research agenda. Drug Alcohol Depend. 2020;212:107993.

    Article  PubMed  PubMed Central  Google Scholar 

  31. First M, Williams JBW, Karg RS, Spitzer RL. Structured clinical interview for Dsm-5 disorders. 1 edition. Arlington,VA: Amer Psychiatric Pub; 2015.

  32. Sheehan DV, Lecrubier Y, Sheehan KH, Amorim P, Janavs J, Weiller E, et al. The Mini-International Neuropsychiatric Interview (M.I.N.I.): the development and validation of a structured diagnostic psychiatric interview for DSM-IV and ICD-10. J Clin Psychiatry. Physicians Postgraduate Press, Inc.; 1998;59:0–0.

  33. Adamson SJ, Sellman JD. A prototype screening instrument for cannabis use disorder: the Cannabis Use Disorders Identification Test (CUDIT) in an alcohol-dependent clinical sample. Drug and Alcohol Review. Taylor & Francis; 2003;22:309–15.

  34. Adamson SJ, Kay-Lambkin FJ, Baker AL, Lewin TJ, Thornton L, Kelly BJ, et al. An improved brief measure of cannabis misuse: the Cannabis Use Disorders Identification Test-Revised (CUDIT-R). Drug Alcohol Depend. 2010;110:137–43.

    Article  PubMed  Google Scholar 

  35. Stephens RS, Roffman RA, Curtin L. Comparison of extended versus brief treatments for marijuana use. J Consult Clin Psychol. 2000;68:898–908.

    Article  CAS  PubMed  Google Scholar 

  36. Budney AJ, Moore BA, Vandrey RG, Hughes JR. The time course and significance of cannabis withdrawal. J Abnorm Psychol. 2003;112:393–402.

    Article  PubMed  Google Scholar 

  37. Allsop DJ, Norberg MM, Copeland J, Fu S, Budney AJ. The Cannabis Withdrawal Scale development: patterns and predictors of cannabis withdrawal and distress. Drug Alcohol Depend. 2011;119:123–9.

    Article  PubMed  Google Scholar 

  38. Simons JS, Gaher RM, Correia CJ, Hansen CL, Christopher MS. An affective-motivational model of marijuana and alcohol problems among college students. Psychol Addict Behav. 2005;19:326–34.

    Article  PubMed  Google Scholar 

  39. Bickel WK, Johnson MW, Koffarnus MN, MacKillop J, Murphy JG. The behavioral economics of substance use disorders: reinforcement pathologies and their repair. Annu Rev Clin Psychol. 2014;10:641–77.

    Article  PubMed  PubMed Central  Google Scholar 

  40. Cassidy RN, Tidey JW, Colby SM, Long V, Higgins ST. Initial development of an E-cigarette purchase task: a mixed methods study. Tob Regul Sci. 2017;3:139–50.

    Article  PubMed  PubMed Central  Google Scholar 

  41. Johnson MW, Bickel WK. The behavioral economics of cigarette smoking: the concurrent presence of a substitute and an independent reinforcer. Behav Pharmacol. 2003;14:137–44.

    Article  CAS  PubMed  Google Scholar 

  42. MacKillop J, Murphy JG, Ray LA, Eisenberg DTA, Lisman SA, Lum JK, et al. Further validation of a cigarette purchase task for assessing the relative reinforcing efficacy of nicotine in college smokers. Exp Clin Psychopharmacol. 2008;16:57–65.

    Article  PubMed  Google Scholar 

  43. Murphy JG, Dennhardt AA, Martens MP, Borsari B, Witkiewitz K, Meshesha LZ. A randomized clinical trial evaluating the efficacy of a brief alcohol intervention supplemented with a substance-free activity session or relaxation training. J Consult Clin Psychol. 2019;87:657–69.

    Article  PubMed  PubMed Central  Google Scholar 

  44. Murphy JG, Dennhardt AA, Skidmore JR, Borsari B, Barnett NP, Colby SM, et al. A randomized controlled trial of a behavioral economic supplement to brief motivational interventions for college drinking. J Consult Clin Psychol. 2012;80:876–86.

    Article  PubMed  PubMed Central  Google Scholar 

  45. Yang C-C, Chiou W-B. Substitution of healthy for unhealthy beverages among college students. A health-concerns and behavioral-economics perspective. Appetite. 2010;54:512–6.

    Article  PubMed  Google Scholar 

  46. Epstein LH, Saelens BE. Behavioral economics of obesity: food intake and energy expenditure. Reframing health behavior change with behavioral economics. Mahwah, NJ, US: Lawrence Erlbaum Associates Publishers; 2000. p. 293–311.

  47. van Mierlo T, Hyatt D, Ching AT, Fournier R, Dembo RS. Behavioral economics, wearable devices, and cooperative games: results from a population-based intervention to increase physical activity. JMIR Serious Games. 2016;4:e1.

    Article  PubMed  PubMed Central  Google Scholar 

  48. Zimmerman FJ. Using behavioral economics to promote physical activity. Prev Med. 2009;49:289–91.

    Article  PubMed  Google Scholar 

  49. MacKillop J, Celio MA, Mastroleo NR, Kahler CW, Operario D, Colby SM, et al. Behavioral economic decision making and alcohol-related sexual risk behavior. AIDS Behav. 2015;19:450–8.

    Article  PubMed  PubMed Central  Google Scholar 

  50. Lemley SM, Fleming III WA, Jarmolowicz DP. Behavioral economic predictors of alcohol and sexual risk behavior in college drinkers. The Psychological Record. Germany: Springer; 2017;67:197–211

  51. Operario D, Kuo C, Sosa-Rubí SG, Gálarraga O. Conditional economic incentives for reducing HIV risk behaviors: integration of psychology and behavioral economics. Health Psychol. 2013;32:932–40.

    Article  PubMed  PubMed Central  Google Scholar 

  52. Herrnstein RJ. The matching law: papers in psychology and economics. Cambridge, MA, US: Harvard University Press; 1997. p. vi, 334.

  53. Hursh SR, Galuska CM, Winger G, Woods JH. The economics of drug abuse: a quantitative assessment of drug demand. Mol Interv. 2005;5:20–8.

    Article  PubMed  Google Scholar 

  54. Aston ER, Meshesha LZ. Assessing cannabis demand: a comprehensive review of the marijuana purchase task. Neurotherapeutics. 2020;17:87–99.

    Article  PubMed  PubMed Central  Google Scholar 

  55. Aston ER, Metrik J, Rosen RK, Swift R, MacKillop J. Refining the marijuana purchase task: Using qualitative methods to inform measure development. Exp Clin Psychopharmacol. 2020;

  56. •• Aston ER, Metrik J, MacKillop J. Further validation of a marijuana purchase task. Drug Alcohol Depend. 2015;152:32–8. (One of the first studies to test performance on a marijuana purchase task in relation to cannabis use outcomes. Using hits as the unit of measurement, individuals who reported any DSM-IV cannabis dependence symptoms reported significantly greater intensity and elasticity of demand than those who endorsed no DSM-IV dependence symptoms.)

    Article  PubMed  PubMed Central  Google Scholar 

  57. Collins RL, Vincent PC, Yu J, Liu L, Epstein LH. A behavioral economic approach to assessing demand for marijuana. Exp Clin Psychopharmacol. 2014;22:211–21.

    Article  PubMed  PubMed Central  Google Scholar 

  58. Vincent PC, Collins RL, Liu L, Yu J, De Leo JA, Earleywine M. The effects of perceived quality on behavioral economic demand for marijuana: a web-based experiment. Drug Alcohol Depend. 2017;170:174–80.

    Article  PubMed  Google Scholar 

  59. Metrik J, Aston ER, Kahler CW, Rohsenow DJ, McGeary JE, Knopik VS, et al. Cue-elicited increases in incentive salience for marijuana: craving, demand, and attentional bias. Drug Alcohol Depend. 2016;167:82–8.

    Article  PubMed  PubMed Central  Google Scholar 

  60. Strickland JC, Lile JA, Stoops WW. Evaluating non-medical prescription opioid demand using commodity purchase tasks: test-retest reliability and incremental validity. Psychopharmacology. 2019;236:2641–52.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  61. Aston ER, Cassidy RN. Behavioral economic demand assessments in the addictions. Curr Opin Psychol. 2019;30:42–7.

    Article  PubMed  PubMed Central  Google Scholar 

  62. •• Zvorsky I, Nighbor TD, Kurti AN, DeSarno M, Naudé G, Reed DD, et al. Sensitivity of hypothetical purchase task indices when studying substance use: a systematic literature review. Prev Med. 2019;105789. (This systematic review examined the relative sensitivity of hypothetical purchase task indices. Purchase tasks are highly effective in revealing relationships between demand and substance-related outcomes, with intensity and Omax exhibiting the greatest sensitivity.)

  63. •• Strickland JC, Campbell EM, Lile JA, Stoops WW. Utilizing the commodity purchase task to evaluate behavioral economic demand for illicit substances: a review and meta-analysis. Addiction. 2020;115:393–406. (This meta-analysis synthesized research assessing commodity purchase tasks for illicit substances to evaluate the magnitude of effect sizes and moderators of the relation between demand indices and measures of quantity, frequency, and severity.)

    Article  PubMed  Google Scholar 

  64. Acuff SF, Amlung M, Dennhardt AA, MacKillop J, Murphy JG. Experimental manipulations of behavioral economic demand for addictive commodities: a meta-analysis. Addiction. 2020;115:817–31.

    Article  PubMed  Google Scholar 

  65. Kaplan BA, Reed DD, Murphy JG, Henley AJ, Reed FDD, Roma PG, et al. Time constraints in the alcohol purchase task. Exp Clin Psychopharmacol. 2017;25:186–97.

    Article  PubMed  Google Scholar 

  66. Teeters J, Meshesha L, Dennhardt A, Murphy J. Elevated demand and proportionate substance-related reinforcement are associated with driving after cannabis use. Can J Addict. 2019;10:42–50.

    Article  Google Scholar 

  67. Minhas M, Balodis I, Aston ER, Murphy JG, MacKillop J. Using an optimized marijuana purchase task to examine cannabis demand in relation to cannabis misuse in heavy drinking emerging adults. J Stud Alcohol Drugs. 2021;82:351–61.

    Article  PubMed  Google Scholar 

  68. Greenwald MK, Sarvepalli SS, Cohn JA, Lundahl LH. Demand curve analysis of marijuana use among persons living with HIV. Drug Alcohol Depend. 2021;220:108524.

    Article  CAS  PubMed  Google Scholar 

  69. Aston ER, Farris SG, MacKillop J, Metrik J. Latent factor structure of a behavioral economic marijuana demand curve. Psychopharmacology. 2017;234:2421–9.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  70. Aston ER, Metrik J, Amlung M, Kahler CW, MacKillop J. Interrelationships between marijuana demand and discounting of delayed rewards: convergence in behavioral economic methods. Drug Alcohol Depend. 2016;169:141–7.

    Article  PubMed  PubMed Central  Google Scholar 

  71. Metrik J, Aston ER, Kahler CW, Rohsenow DJ, McGeary JE, Knopik VS, et al. Cue-elicited increases in incentive salience for marijuana: craving, demand, and attentional bias. Drug Alcohol Depend. 2016;

  72. •• Amlung M, MacKillop J. Availability of legalized cannabis reduces demand for illegal cannabis among Canadian cannabis users: evidence from a behavioural economic substitution paradigm. Can J Public Health. 2019;110:216–21. (Results from this work indicate that the availability of legal cannabis reduces demand for illegal cannabis, but only at certain prices. When legal cannabis was priced upwards of $12/gram, preferences switched to the alternative illegal option.)

    Article  PubMed  Google Scholar 

  73. Bergeria CL, Dolan SB, Johnson MW, Campbell CM, Dunn KE. Evaluating the co-use of opioids and cannabis for pain among current users using hypothetical purchase tasks. J Psychopharmacol. 2020;34:654–62.

    Article  PubMed  PubMed Central  Google Scholar 

  74. Strickland JC, Lile JA, Stoops WW. Unique prediction of cannabis use severity and behaviors by delay discounting and behavioral economic demand. Behav Processes. 2017;140:33–40.

    Article  PubMed  PubMed Central  Google Scholar 

  75. McIntyre-Wood C, Minhas M, Balodis I, Murphy JG, MacKillop J. A reinforcer pathology approach to cannabis misuse: evaluation of independent and interactive roles of cannabis demand and delay discounting in a sample of community adults. Exp Clin Psychopharmacol. 2021;

  76. Patel H, Amlung M. Elevated cannabis demand is associated with driving after cannabis use in a crowd-sourced sample of adults. Exp Clin Psychopharmacol. 2019;27:109–14.

    Article  PubMed  Google Scholar 

  77. Dolan SB, Spindle TR, Vandrey R, Johnson MW. Behavioral economic interactions between cannabis and alcohol purchasing: associations with disordered use. Exp Clin Psychopharmacol. 2020;

  78. Naudé GP, Reed DD, Thornton TJ, Amlung M. Dual use of alcohol and cannabis among college students: a reinforcer pathologies approach. Exp Clin Psychopharmacol. 2020;

  79. Aston ER, Farris SG, Metrik J, Rosen RK. Vaporization of marijuana among recreational users: a qualitative study. J Stud Alcohol Drugs. 2019;80:56–62.

    Article  PubMed  PubMed Central  Google Scholar 

  80. Connor JP, Stjepanović D, Le Foll B, Hoch E, Budney AJ, Hall WD. Cannabis use and cannabis use disorder. Nature Reviews Disease Primers. Nature Publishing Group; 2021;7:1–24.

  81. Davis ML, Powers MB, Handelsman P, Medina JL, Zvolensky M, Smits JAJ. Behavioral therapies for treatment-seeking cannabis users: a meta-analysis of randomized controlled trials. Eval Health Prof. 2015;38:94–114.

    Article  PubMed  Google Scholar 

  82. Bujarski S, MacKillop J, Ray LA. Understanding naltrexone mechanism of action and pharmacogenetics in Asian Americans via behavioral economics: a preliminary study. Exp Clin Psychopharmacol. 2012;20:181–90.

    Article  PubMed  PubMed Central  Google Scholar 

  83. MacKillop J, Murphy JG. A behavioral economic measure of demand for alcohol predicts brief intervention outcomes. Drug Alcohol Depend. 2007;89:227–33.

    Article  PubMed  Google Scholar 

  84. Murphy CM, MacKillop J, Martin RA, Tidey JW, Colby SM, Rohsenow DJ. Effects of varenicline versus transdermal nicotine replacement therapy on cigarette demand on quit day in individuals with substance use disorders. Psychopharmacology. 2017;234:2443–52.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  85. Cassidy RN, Bernstein MH, Magill M, MacKillop J, Murphy JG, Colby SM. Alcohol demand moderates brief motivational intervention outcomes in underage young adult drinkers. Addict Behav. 2019;98:106044.

    Article  PubMed  PubMed Central  Google Scholar 

  86. Hudak M, Severn D, Nordstrom K. Edible cannabis-induced psychosis: intoxication and beyond. Am J Psychiatry. 2015;172:911–2.

    Article  PubMed  Google Scholar 

  87. Ghosh TS, Van Dyke M, Maffey A, Whitley E, Erpelding D, Wolk L. Medical marijuana’s public health lessons–implications for retail marijuana in Colorado. N Engl J Med. 2015;372:991–3.

    Article  CAS  PubMed  Google Scholar 

  88. Spindle TR, Cone EJ, Herrmann ES, Mitchell JM, Flegel R, LoDico C, et al. Pharmacokinetics of cannabis brownies: a controlled examination of Δ9-tetrahydrocannabinol and metabolites in blood and oral fluid of healthy adult males and females. J Anal Toxicol. 2020;44:661–71.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  89. Vandrey R, Raber JC, Raber ME, Douglass B, Miller C, Bonn-Miller MO. Cannabinoid dose and label accuracy in edible medical cannabis products. JAMA. 2015;313:2491–3.

    Article  CAS  PubMed  Google Scholar 

  90. Gunn RL, Aston ER, Sokolovsky AW, White HR, Jackson KM. Complex cannabis use patterns: associations with cannabis consequences and cannabis use disorder symptomatology. Addict Behav. 2020;105:106329.

    Article  PubMed  PubMed Central  Google Scholar 

  91. Krauss MJ, Rajbhandari B, Sowles SJ, Spitznagel EL, Cavazos-Rehg P. A latent class analysis of poly-marijuana use among young adults. Addict Behav. 2017;75:159–65.

    Article  PubMed  Google Scholar 

  92. Baggio S, Deline S, Studer J, Mohler-Kuo M, Daeppen J-B, Gmel G. Routes of administration of cannabis used for nonmedical purposes and associations with patterns of drug use. J Adolesc Health. 2014;54:235–40.

    Article  PubMed  Google Scholar 

  93. Craft S, Winstock A, Ferris J, Mackie C, Lynskey MT, Freeman TP. Characterising heterogeneity in the use of different cannabis products: latent class analysis with 55 000 people who use cannabis and associations with severity of cannabis dependence. Psychol Med. 2020;50:2364–73.

    Article  PubMed  Google Scholar 

  94. Wu L-T, Zhu H, Swartz MS. Trends in cannabis use disorders among racial/ethnic population groups in the United States. Drug Alcohol Depend. 2016;165:181–90.

    Article  PubMed  PubMed Central  Google Scholar 

Download references

Funding

Funding for this research was supported by NIDA grant K01DA039311 (Aston), NIGMS COBRE grant P20GM130414 (Aston), and NIAAA grant T32AA007459 (Berey). All funding sources had no other role in study design or manuscript preparation other than financial support.

Author information

Authors and Affiliations

  1. Center for Alcohol and Addiction Studies, Brown University School of Public Health, Box GS121-5, Providence, RI, 02912, USA

    Elizabeth R. Aston & Benjamin L. Berey

  2. Department of Behavioral and Social Sciences, Brown University School of Public Heath, Providence, RI, 02912, USA

    Elizabeth R. Aston

Authors
  1. Elizabeth R. Aston
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Benjamin L. Berey
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Elizabeth R. Aston.

Ethics declarations

Conflict of Interest

The authors declare no competing interests.

Additional information

Publisher's note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

This article is part of the Topical Collection on Cannabis

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Aston, E.R., Berey, B.L. Cannabis Use Disorder: A Behavioral Economic Perspective. Curr Addict Rep 9, 1–13 (2022). https://doi.org/10.1007/s40429-021-00405-4

Download citation

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s40429-021-00405-4

Keywords

Search

Navigation